ĀÜĄņĀŅĀ×

Scott Megill is President and Chief Executive Officer of Coriell Life Sciences (CLS). With a vision to translate decades of cutting-edge genetic research into insights that empower the most precise medical care, Scott launched Coriell Life Sciences out of the renowned Coriell Institute for Medical Research in 2013. Under his leadership, CLS earned recognition as IBMā€™s Global Entrepreneur of the Year and has grown to become an internationally trusted provider of comprehensive medication risk management solutions, bioinformatics, and genetic interpretation and reporting services. Pioneering innovation in precision medicine, Scott is a driving force in setting the industry standard for pharmacogenomics and advancing a healthier world.

An entrepreneurial leader recognized for unlocking the power of technology to fuel smarter healthcare, Scott spearheads collaboration with major healthcare providers, payers, employers, physicians, and other providers to help improve lives and reduce healthcare costs. He is passionate about educating others and is an advocate for the advancement of precision medicine through his involvement with organizations, including the Employer and Provider Health Innovation Roundtables, Personalized Medicine Coalition, Business Group on Health, Health Action Council, among others.

Scott previously served as CIO at the Coriell Institute for Medical Research and held business technology leadership roles at Dow Chemical Company and Rohm and Haas. He also founded the Moorestown Robotics Club, an organization that immerses New Jersey elementary, middle, and high school students in the excitement of science and technology through international robotics competitions.

Scott holds an Executive Master of Business Administration degree from Villanova University and a Bachelor of Arts degree in English and Philosophy from Drew University.